JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma	esophageal small cell neuroendocrine carcinoma	Recruiting	Phase 2	2025-07-16		NCT05173246

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CSPC Ouyi Pharmaceutical Co., Ltd.	28
Shanghai Junshi Bioscience Co., Ltd.	42
Sun Yat-sen University	606
The First Affiliated Hospital of Zhengzhou University	203

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-sen University Cancer Center	Guangzhou	China	315

Clinical trials